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Mesenchymal stromal cells (MSCs) have beenextensively utilized for various cell therapeutic trials, but the signals regulating their stromal
function remain largely unclear. Here, we show that canonical Wnt signals distinctively regulate MSCs in a biphasicmanner depending on
signal intensity, i.e., MSCs exhibit proliferation and progenitor self-renewal under low Wnt/β-catenin signaling, whereas they exhibit
enhanced osteogenic differentiation with priming to osteoblast-like lineages under high Wnt/β-catenin signaling. Moreover, low or
high levels of β-catenin in MSCs distinctly regulated the hematopoietic support of MSCs to promote proliferation or the
undifferentiated state of hematopoietic progenitors, respectively. A gene expression study demonstrated that different
intracellular levels of β-catenin in MSCs induce distinct transcriptomic changes in subsets of genes belonging to different gene
function categories. Different β-catenin levels also induced differences in intracellular levels of the β-catenin co-factors,
Tcf-1 and Lef-1. Moreover, nano-scale mass spectrometry of proteins that co-precipitated with β-catenin revealed distinctive
spectra of proteins selectively interacting with β-catenin at specific expression levels. Together, these results show that Wnt/
β-catenin signals can coax distinct transcription milieu to induce different transcription profiles in MSCs depending on the signal
intensity and that fine-tuning of the canonical Wnt signaling intensity can regulate the phase-specific functionality of MSCs.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Mesenchymal stromal cells (MSCs) are non-hematopoietic
adherent cell populations derived from stroma of bone
marrow (BM), adipose tissue, or placental tissue (Keating,
2006; Pittenger et al., 1999). These MSCs are being utilized⁎ Corresponding author at: Catholic High-Performance Cell Therapy
Center, The Catholic University of Korea, 505, Banpo-Dong, Seocho-Ku,
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1873-5061/© 2015 The Authors. Published by Elsevier B.V. This
(http://creativecommons.org/licenses/by-nc-nd/4.0/).for therapeutic trials, facilitating the establishment of a
regenerative microenvironment for hematopoietic stem
cells (HSCs), neuronal stem cells, and other tissue-specific
stem cells (Frenette et al., 2013; Murphy et al., 2013; Satija
et al., 2009). MSCs exert therapeutic effects via paracrine
secretion of various growth factors that can stimulate
regeneration of injured tissues (Caplan and Correa, 2011).
In addition, MSCs exert niche effects on endogenous stem
cells through cell–cell interactions, as typically exemplified
by the BM stem cell niche in the endosteal and peri-vascular
regions (Oh and Humphries, 2012; Oh and Kwon, 2010).is an open access article under the CC BY-NC-ND license
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ties of MSCs exert regulatory influences on tissue regenerative
activity. For example, adipogenic differentiation of MSCs in
BM suppresses the regeneration of HSCs in myeloablated hosts
(Naveiras et al., 2009), whereas cells of the osteoblastic
lineage support hematopoietic activity (Calvi et al., 2003;
Zhang et al., 2003). In addition, the differentiation status of
MSCs also influences the niche activity, i.e., recent studies
have shown that among the heterogeneous subpopulation of
MSCs in BM, primitive subsets of MSCs including prx-1(+) MSCs
(Greenbaum et al., 2013) and nestin (+) MSCs (Mendez-Ferrer
et al., 2010) play a major role in regulating HSC self-renewal
in the perivascular niche of the BM. Accordingly, extensive
studies are under way to identify the signals and molecular
mechanisms that control the proliferation/self-renewal
and differentiation of MSCs under various physiological and
pathological conditions.
Wnts are secreted glycoproteins associated with the cell
surface or extracellular matrix that influence diverse biolog-
ical processes, including embryonic induction and cell fate
specification. In the canonical Wnt signaling pathway, Wnt
binds to seven-pass transmembrane Frizzled (Fz) family
receptors and the single-pass co-receptors LRP 5, 6 (LDL-
receptor-related protein 5,6), to induce β-catenin stabiliza-
tion. Subsequently, the stabilized β-catenin translocates to
the nucleus and forms a complex with the DNA-binding
transcription factors TCF/LEF to activate a Wnt-controlled
gene expression program (Kikuchi et al., 2006).
Several studies have shown that canonical wnt signaling
plays a critical role in regulating cell fate decisions of MSCs,
but variable biological effects on MSCs have been reported,
i.e., up-regulation of canonical wnt signaling stimulated the
proliferation of MSCs, inhibited their osteogenic differentia-
tion, or promoted their osteogenic commitment (Boland et al.,
2004; Cook et al., 2014; Gaur et al., 2005; Kawai et al., 2007;
Takada et al., 2009), indicating that multiple, complex effects
are mediated by canonical wnt signals.
In addition to the proliferation and differentiation of MSCs,
canonical wnt signaling has been implicated in the regulation
of the stromal activity of MSCs. For example, we and others
recently showed that activation of Wnt/β-catenin signals in
MSCs enhances the self-renewal of HSCs by triggering cross-
talk of Wnt-Notch signals in the stem cell niche (Kim et al.,
2009; Oh, 2010), and intra-femoral injection of β-catenin-
stabilized MSCs promotes regeneration of HSCs (Ahn et al.,
2010). Similarly, β-catenin expression in the BM stroma
was shown to be necessary for maintenance of long-term
hematopoietic cells (Kim et al., 2009; Nemeth et al., 2009). In
contrast, myeloproliferative diseases developed in transgenic
mice with constitutive activation of β-catenin in bonemarrow
osteoblastic cells (Kode et al., 2014), indicating that canonical
Wnt signals in MSCs should be fine-tuned for their coordinated
stromal function.
However, the regulatory mode of Wnt/β-catenin signals
for MSCs, especially with regard to signaling intensity,
remains unclear. Therefore, in this study, to precisely
characterize the biological effects of canonical wnt signaling
in MSCs, we investigated the possibility that MSCs are
distinctively regulated by fine-tuning of canonical Wnt
signaling. We show that β-catenin can cause distinct
transactivation in MSCs depending on its level of accumu-
lation, resulting in distinct behavior of MSCs. Our studyreveals the fine-tuning of Wnt/β-catenin signaling for coordi-
nation of MSC function.
Materials and methods
Animals and cells
C57BL/6J-Ly 5.2 (BL6) from Jackson Laboratory (Bar Harbor,
ME, USA) were used in the experiments under the approval
from the Animal Experiment Board of the Catholic University
of Korea. Enrichment of hematopoietic progenitors by 5-
fluorouracil (5-FU BMCs) was performed as described (Kim et
al., 2009). MSCs were isolated and passage cultured until
become negative for CD45 as described (Kim et al., 2009) and
characterized by surface phenotype (Supplemental Fig. 1).
Construction of expression plasmids, retrovirus
production, and transduction of MSCs
A stable form of the β-catenin gene (S37A) (Kim et al., 2009)
was cloned into two types of retroviral vector, MPG
(MSCV-PGK-GFP) or QGCX2 (CMV-GFP-IRES). MSCs were
transduced with each retroviral vector with multiplicity of
infection (MOI) of 30, then sorted for transduced (GFP+) cells
as described (Hong et al., 2014).
Reporter assay
The TOPFLASH and FOPFLASH reporter constructs containing
eight TCF/LEF binding sites or mutated binding sites (Biechele
andMoon, 2008)were transfected into cells alongwith effector
plasmids. Luciferase activity was measured by the Luciferase
Assay System (Promega Corp., Madison, WI) according to the
manufacturer's instructions. Transfection efficiency was nor-
malized for β-galactosidase activity. To measure osteocalcin
promoter activity, p6OSE2-luc containing six copies of the
Runx2 binding site in the osteocalcin promoter regionwas used
(Jung et al., 2009).
Cell proliferation and BrdU incorporation assay
Cell proliferation assay (4 days) for transduced (GFP+) MSCs
and their BrdU incorporation (12 h) were analyzed as previ-
ously described (Jung et al., 2009), visualized by secondary
antibody conjugated with Alexa-593 (Molecular Probes,
Eugene, OR), then mounted with DAPI (Molecular Probes) for
analysis.
Colony formation and osteogenic and adipogenic
differentiation of MSCs
Osteogenic and adipogenic differentiation of MSCs was
performed as previously described (Jung et al., 2009),
followed by Alizarin Red S (Sigma, St Louis, MO) or Oil Red
O (Sigma) staining, respectively. The osteogenic mineraliza-
tion or adipogenic lipid droplets were eluted and quantita-
tively measured by spectrophotometry at 570 and 520 nm,
respectively. For colony formation, MSCs were maintained
for 6 days under low (10 ng/ml) and high (100 ng/ml)
concentrations of recombinant Wnt3a ligand and plated at
358 J.-A. Kim et al.a density of 1000 cells per 100-mm dish. After incubation for
14 days, colonies (N50 cells) were fixed and stained with
crystal violet (Sigma).
In-vivo ossification of MSCs in subrenal capsule
MSCs (1 × 105 each) were preconditioned (24 h), resuspended
in Matrigel (with 100 ng/ml rhBMP-2) and inoculated under-
neath the renal capsule of 11 week old mice as previously
described (Chan et al., 2009). After 2 weeks, the kidneys were
dissected and fixed and paraffin sections were stained with
either H&E or Alizarin Red stains. For immunohistochemistry
staining of GFP, sections were stained with anti-GFP anti-
body (Abcam, Cambridge, UK), visualized with DAB substrate
kit (BD Pharmingen), and followed by counterstaining with
hematoxylin.
Measurement of β-catenin protein levels in the
fresh bone marrow stromal cells
Fresh bone marrow cells were stained with antibodies against
CD45, CD31, Ter119 (BD Pharmingen), and Leptin Receptor
(Sigma). Stained cells were fixed and permeabilized with
Fixation or permeabilization buffer (eBioscience), and then
stained with anti-β-catenin antibody and anti-rabbit Cy5
(Bethyl Laboratories, Montgomery, USA) as described (Kim et
al., 2009).
Nuclear extract and Western blot
For Western blot, MSCs were lysed in 2× Laemmli buffer,
boiled for 5 min and cleared before electrophoresis. Nuclear
extraction of MSCs was performed using NE-PER nuclear and
cytoplasmic extraction reagents (Thermo). The membranes
were probed with antibodies against HA (Sigma), active β-
catenin (Merck Millipore, Billerica, MA), β-actin (Millipore),
LEF1, TCF1 (Cell Signaling), TCF3, and TCF-4 (Santa Cruz).
Co-culture of hematopoietic cells andMSCs expressing
β-catenin
MSCs transduced with each retroviral vector (GFP+) were
irradiated (1500 cGy) and co-cultured with 5-FU BMCs for
5 days in the presence of growth factors as described (Kim et
al., 2009). The undifferentiated phenotype of co-cultured
hematopoietic cells was analyzed by as previously described
(Kim et al., 2009).
Microarray analysis
A gene expression study using microarrays was performed
as previously described (Hong et al., 2014). Briefly, biotin-
labeled cRNA samples were prepared using the Illumina
TotalPrep RNA Amplification kit (Ambion, Austin, TX) and
hybridized to a version 2 of the Illumina Mouse-6 BeadChip
(48 K) according to the manufacturer's instructions (Illumina,
San Diego, CA). Array data were analyzed using Illumina
BeadStudio software. Average linkage hierarchical cluster
analysis was performed with a 1-Pearson correlation as a
similarity metric using the GeneCluster/TreeView program(http://rana.lbl.gov/EisenSoftware.htm). In total, 134 unique
genes were selected by t-test (p b .005) with false discovery
rate (FDR b 0.1) statistical confidence; the expression of
these genes was increased by three-fold or more in MPG-
β-catenin or QG-β-catenin compared with MPG or QG. The
Gene Ontology program (http://david.abcc.ncifcrf.gov/) was
then used to categorize genes in subgroups based on their
biologic function.
Co-immunoprecipitation of β-catenin
Co-immunoprecipitation of proteins was performed as previ-
ously described (Antrobus and Borner, 2011). Briefly, cells
were lysed and incubated with mouse anti-immunoglobulin G
and anti-HA antibodies (Sigma), added with protein G plus/
protein A-agarose beads (Calbiochem, Darmstadt, Germany),
then precipitated, and subjected to proteomic analysis.
Nano-scale liquid chromatography/mass spectrometry
of proteins co-precipitated with β-catenin
NanoLC–MS/MS analysis was performed on an Agilent 1100
Series Nano-LC and LTQ-mass spectrometer (Thermo Electron,
San Jose, CA) as previously described (Gaspari and Cuda,
2011). Mass spectra were acquired using data-dependent
acquisition with full mass scan (400–1800 m/z) followed by
MS/MS scans. Each MS/MS scan acquiredwas an average of one
microscan on the LTQ.
Database searching for proteomic analysis
The RAW files were converted and then searched using
Mascot Server 2.2 (Matrix Science, Boston, MA). The data
were searched against the NCBI human database (v.110704).
Within the Mascot search, trypsin was selected as the
enzyme, and one missed cleavage was allowed per peptide.
All spectral count values were reported across samples, and
only the proteins that included at least a top-ranked peptide
and were reported in all samples were considered in the
spectral counting analysis.
Statistical analysis
Data are expressed as the mean ± SEM. The significance
of differences between groups was analyzed using Student's
t test. p b 0.05 was considered to be statistically significant
(* p b 0.05, ** p b 0.01, *** p b 0.001, **** p b 0.0001).
Results
Establishment of bone marrow MSCs expressing high
and low levels of active β-catenin protein
To establish MSCs that express high and low levels of
β-catenin, we employed two types of retroviral vectors
encoding the active form of β-catenin (S37A), where the
expression of the coding gene was driven by the viral LTR
(MPG-β-catenin) or CMV promoter (QG-β-catenin) (Figs. 1A,
B). When each retroviral vector was transduced into 293T
cells or primary BM-derived MSCS along with the TOPFLASH
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transactivation of the target reporter gene than the MPG-
β-catenin vector in both types of cells (108- and 38-fold higher
in 293T cells and MSCs, respectively) (Fig. 1C). Moreover, BM-
derived MSCs transduced with QG-β-catenin exhibited a much
higher level of β-catenin protein expression compared to
the levels in MSCs transduced with MGP-β-catenin (Fig. 1D).
However, MSCs transduced with MPG-β-catenin exhibited only
modestly increased levels of transactivation and protein levels
compared to basal levels in control group MSCs (Fig. 1C right,
Fig. 3D). These results show that these two types of MSCs
can be employed as a model for MSCs expressing high (MSC-
QG-β-catenin; H-BC/MSC) or low (MPG-β-catenin; L-BC/MSC)
levels of β-catenin.Only a low level of active β-catenin accumulation
promotes the proliferation and self-renewal of
colony-forming mesenchymal progenitors
We first compared the morphology and proliferation of MSCs
expressing high and low levels of β-catenin during in-vitro
culture. As shown in Fig. 2A, MSCs expressing high levels of
β-catenin (H-BC/MSCs) exhibited a larger size than those
expressing low levels of β-catenin (L-BC/MSC), as deter-
mined by flow cytometry plots. In addition, the L-BC/MSCs
exhibited higher proliferative activity during in vitro culture
than the control MSCs, whereas H-BC/MSCs exhibited
significantly lower proliferation than the control (Fig. 2B).Figure 1 Establishment of MSCswith different intracellular levels of
of β-catenin replacing serine S37 into Ala. TCF/LEF, T-cell factor-1/
hemagglutinin-tag. (B): Retroviral constructs encoding green fluoresce
(C): Comparisons of transactivation potential of β-catenin in 293
Transactivation was assayed by luciferase activity in each transduce
transactivation of reporter genes by β-catenin was determined by the
shown (3 replicates, n = 9). (*: p b 0.05, **; p b 0.01). (D): Expression o
vector. Shown are the representative Western blots using antibodies a
active β-catenin protein relative to β-actin compared to control MSCsSimilarly, BrdU uptake was increased in L-BC/MSCs but
decreased in H-BC/MSCs (Fig. 2C), indicating that MSC pro-
liferation is promoted predominantly under low levels of
β-catenin accumulation. Consistent with this finding, the
c-myc expression level was increased in L-BC/MSCs but
decreased in H-BC/MSCs compared to control MSCs (Fig. 2D).
Together, these results show that β-catenin exerts different
effects on the proliferation of MSCs depending on its level of
expression in MSCs.
Next, we examined the effects on the colony formation
(CFU-F) of MSCs by plating equivalent numbers of MSCs in
each group. The colony formation of L-BC/MSCs was en-
hanced compared to that of control MSCs, whereas that of
H-BC/MSCs was decreased (Fig. 3A). In addition, the colonies
that formed from L-BC/MSCs were larger than those from
H-BC/MSCs (Fig. 3B), reflecting the higher proliferative
activity of MSCs during the colonization process. However,
no difference was observed for the survival and senescence
of MSCs expressing high or low levels of β-catenin (Supple-
mental Fig. 2). Moreover, L-BC/MSCs exhibited higher
expression of genes associated with the primitive state of
MSCs, such as Oct-4, Nanog, Sox-2, and Nestin (Greco et al.,
2007; Tsai et al., 2012), than H-BC/MSCs (Fig. 3C). These
results show that only low-level accumulation of β-catenin
can support the maintenance and self-renewal of MSC
progenitors that are capable of forming colonies.
To further examine these effects, we examined whether
differences in the concentration of Wnt ligands could induce
similar differences in MSCs by treating non-transduced MSCsactiveβ-catenin. (A): Schematic representation of the active form
lymphoid enhancing factor-1 binding site; HA, human influenza
nce protein (GFP) alongwith β-catenin under different promoters.
T cells (left) or primary bone marrow-derived MSCs (right).
d cell after normalization against β-galactosidase activity. The
folds of TOP/ FOP ratio relative to that of control. Mean ± SEM is
f β-catenin proteins in MSCs transduced by each type of retroviral
gainst indicated proteins (left) and their folds expression levels of
(right) with SE (3 exp. n = 3). (*: p b 0.05, **; p b 0.01).
Figure 2 Distinct effects of different levels of β-catenin on MSC proliferation. (A): Representative flow cytometry plots for MSCs
with low and high expression of β-catenin. (B,C): Proliferation of MSCs with low and high expression of β-catenin was compared with
control transduced MSCs (B) and % of BrdU+ cells among DAPI+ was compared for each group of MSCs (C). Means ± SEM are shown
(3 experiments, n = 9, **; p b 0.01). (D): Expression of c-myc in MSCs with low and high β-catenin. Shown are the representative
RT-PCR plot (upper) and fold expression level normalized to GAPDH levels relative to the control (lower).
360 J.-A. Kim et al.with high (100 ng/ml) and low (10 ng/ml) concentrations of
Wnt3a ligand. As shown in Figs. 3D and E, high and low
concentrations of Wnt3a ligand produced similar differences
in the protein levels of β-catenin and transactivation of the
TOPFLASH reporter (Figs. 3D and E), which produced similar
increases and decreases in CFU-F numbers, respectively
(Fig. 3F), reproducing the effects of expressing high and low
levels of β-catenin MSCs. Next, we examined the relation
between β-catenin levels and CFU-Fs by comparing the levels
in fresh bonemarrow stromal cells. As shown, the stromal cells
expressing leptin receptor, the primitive subsets of MSCS that
was shown to be highly enriched with CFU-F (Zhou et al.,
2014), exhibited lower level of β-catenin protein than leptin
receptor (−) cells, thus showing similar correlation between
higher CFU-Fs and lower level β-catenin levels under in-vivo
conditions (Fig. 3G).
These results together show that the strength of Wnt/
β-catenin signaling in MSCs exerts distinct effects on the
proliferation and self-renewal of MSC progenitors, pointing to
a dose-specific response of MSCs to Wnt/β-catenin signals.Differentiation of MSCs is regulated by β-catenin
distinctly from colonization and proliferation
We examined the effects of β-catenin levels on differenti-
ation of MSCs towards osteogenic or adipogenic lineages. As
shown in Fig. 4A, osteogenic differentiation was increased in
L-BC/MSCs compared to control MSCs, and differentiationwas further increased with high levels of β-catenin (H-BC/
MSC). In contrast, adipogenic differentiation of MSCs was
decreased in L-BC/MSCs compared to control MSCs, and this
inhibition of adipogenic differentiation was also further
decreased under high accumulation of β-catenin (H-BC/
MSCs) (Fig. 4B), indicating that the differentiation of MSCs is
regulated by Wnt/β-catenin signals in a manner dependent
on β-catenin levels.
Interestingly, β-catenin accumulation in proliferating MSCs
caused priming of MSCs towards osteogenic lineages and away
from adipogenic lineages, i.e., β-catenin-expressing MSCs (at
both low and high levels) already had higher expression of
osteogenic genes (ALP and OC) with a higher percentage of
ALP(+) cells and lower expression of adipogenic genes (PPAR-γ
and αP2) than control MSCs even before the induction of
differentiation (Fig. 4C, 4D). Similarly, MSCs treatedwith a high
concentration of Wnt3a ligand exhibited higher osteocalcin
promoter activity during the proliferation phase (Fig. 4E). In
addition, MSCs that had been treated with a high concentra-
tion of Wnt3a ligand exhibited enhanced mineral deposition
when induced to differentiate (Fig. 4F), indicating that Wnt/
β-catenin signals prime MSCs towards osteogenic lineages in a
manner proportional to the intensity of the signals.
Moreover, when the MSCs expressing high and low levels
of β-catenin were inoculated into subrenal capsule for
in-vivo ossification (Chan et al., 2009), L-BC/MSCs exhibited
increased levels of osteogenic mineralization than control
MSCs, which was further increased in the H-BC/MSCs
(Fig. 4G), indicating that the in-vitro findings on effects of
Figure 3 Distinct effects of signal intensity of Wnt/β-catenin on self-renewal of mesenchymal progenitors. (A): Comparisons of CFU-F
in MSCs with high and low expression of β-catenin. The number of colonies from 1000 cells of each group of MSCs is shown (mean ± SEM, 3
experiments, n = 9). **; p b 0.01. (B): Representative morphology of colonies stained with crystal violet (scale bar = 50 μm). (C): Effects
ofβ-catenin level in MSCs on expression of pluripotency-related genes. Expression of each indicated genewas analyzed by RT-PCR in MSCs
transduced with each retroviral vector encoding β-catenin. (D–F): Concentration effects of recombinant Wnt3a ligand on MSCs. (D) The
accumulation of β-catenin under each dose of Wnt3a ligand was analyzed by Western blot (E). Transactivation of reporters in MSCs
treated with low (10 ng/ml) or high (100 ng/ml) concentrations of recombinant Wnt3a ligand was analyzed by relative folds of TOP/FOP
ratios after normalization against β-galactosidase activity. (F) MSCs maintained for 6 days under low and high concentrations
of recombinant Wnt3a ligand were plated for colony formation. The mean number of CFU-Fs from 1000 MSC cells is shown with the SEM
(3 replicates, n = 3 each). *; p b 0.05, **; p b 0.01. (G): Comparisons of β-catenin protein levels in subsets of fresh BM stromal cells. Fresh
BM cells were analyzed by intracellular staining for β-catenin protein. Shown are the representative flow cytometry plot for Leptin
Receptor (+) or (−) cells among MSCs (CD45/31/Ter119-) (upper) and levels of β-catenin protein in each subset of MSCs represented by
specific mean fluorescent intensity (Δ M.F.I.) normalized by those of isotype control (n = 3) (lower).
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differentiation of MSCs.
Thus, in contrast to the proliferation/self-renewal of MSCs
observed under low levels of Wnt/β-catenin, a high level of
Wnt/β-catenin drives MSC differentiation from adipogenic to
osteogenic lineages, indicating that two distinct aspects of
MSC function aremodulated by the intensity of Wnt/β-catenin
signal.Distinct niche activity of MSCs according to
β-catenin stabilization level
Because previous studies have shown that β-catenin stabili-
zation in MSCs stimulates HSC self-renewal and maintenance(Kim et al., 2009; Nemeth et al., 2009), we next examined
whether this hematopoiesis-supporting function of MSCs is
distinctively regulated by the strength of Wnt/β-catenin
signaling in MSCs. To examine the possibility, L-BC/MSCs or
H-BC/MSCs were used as a feeder layer and co-cultured with
hematopoietic progenitors (5-FU treated BM cells) for 5 days.
When the proliferation of hematopoietic cells (CD45+) was
analyzed during co-culture with MSCs, L-BC/MSCs supported
the expansion of hematopoietic cells to a level comparable to
that in control MSCs, but H-BC/MSCs induced significantly
lower proliferation of the hematopoietic cells. In contrast, the
frequency of phenotypically defined HSCs (Lin-Sca-1+c-kit+; LSK)
was significantly higher in the co-culture on H-BC/MSCs than in
the co-culture on L-BC/MSCs or control/MSCs (Fig. 5B). Thus,
whereas the net expansion of undifferentiated hematopoietic
Figure 4 Concentration effects of β-catenin on the osteogenic and adipogenic differentiation of MSCs. (A, B): Effects of β-catenin
levels on osteogenic and adipogenic differentiation. Each group MSC was subjected to osteogenic or adipogenic differentiation and
stained with Alizarin-Red S or Oil Red O, respectively. Representative staining profiles (left, 100×) and spectrophotometric
quantification of osteogenic (A) and adipogenic differentiation (B) are shown (mean ± SEM, from 3 experiments, n = 6). **; p b 0.01.
***; p b 0.001, ****; p b 0.0001. (C): Expression of osteogenic and adipogenic genes. Representative plots for RT-PCR analysis of
osteogenic genes (upper) and adipogenic genes (lower) in each group of MSCs before (D + 0) and 5 days after differentiation induction
(D + 5) are shown. (D): ALP activity in MSCs expressing β-catenin. Representative images (100×) and % of ALP(+) cells are shown
(mean ± SEM, from 3 experiments, n = 9). *; p b 0.05, **; p b 0.01. (E): Concentration effects of Wnt3a ligand on osteocalcin
promoter activity in MSCs. MSCs pre-treated with the indicated concentrations of recombinant Wnt3a were transfected with
osteocalcin promoter reporters (6OSE2-luc). The mean ± SEM of the fold transactivation of osteocalcin reporters in each type of
treated MSC is shown relative to that in BSA-treated MSCs (3 experiments, n = 9). **; p b 0.01. (F): Concentration effects of Wnt3a
ligand on osteogenic differentiation. MSCs pre-treated with each indicated concentration of Wnt3a ligand were subjected to
osteogenic differentiation. Quantification of mineral deposition 5 days after induction of differentiation is shown (mean ± SEM values
from 3 experiments, n = 6). **; p b 0.01. (G): Effect of β-catenin dose on the in-vivo osteogenic differentiation. Each indicated MSC
group was inoculated into subrenal capsules in a mixture of Matrigel and kidneys were analyzed 2 weeks after injection.
Representative images are shown for gross morphology, fluorescence (GFP), hematoxylin & eosin staining, immunohistochemical
staining for GFP and Alizarin-red staining for mineralization. NC, group transplanted only with Matrigel without MSCs. The white
arrows indicate bonny area in the kidney, and the black arrows indicate mineralized nodules with alizarin red staining. Note
comparable level of transplanted (GFP+) cells for each injected MSC group.
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β-catenin-stabilized MSCs compared to the control group
(Fig. 5C), high and low levels of β-catenin promoted distinct
modes of self-renewal, predominantly supporting the mainte-
nance of the undifferentiated state or the proliferation of the
cells, respectively.
To explore the molecular basis for this distinction in
hematopoietic support, we compared these two types of
MSCs for expression of microenvironmental cross-talk mole-
cules such as Notch ligand, CXCL-12 (Greenbaum et al.,
2013), and Ang-1 (Arai et al., 2004). As shown in Fig. 5D,
MSCs expressing high and low levels of β-catenin exhibited
comparable levels of expression of Ang-1 (Arai et al., 2004)
and CXCL-12 (Greenbaum et al., 2013). In contrast, a
difference was observed for molecules involved in Notch
signaling such as Jagged-1 or Mfap2 (microfibril-associated
glycoprotein 2, proliferin-2) (Choong et al., 2003); these
molecules were expressed at a higher level in L-BC/MSCs
than in H-BC/MSCs. Together, these results show that
different levels of β-catenin in MSCs can provide distinctFigure 5 Distinct hematopoietic supporting activity of MSCs accor
on each indicated MSC group for 5 days and analyzed for expansion
hematopoietic cells compared to input cells (mean ± SEM values from
Sca-1+c-kit+) cells in hematopoietic cells (CD45+) after coculture
p b 0.05 **; p b 0.01. (C): Net expansion of LSK cells after co-cultur
input LSK cell number are shown (mean ± SEM values from 3 expe
regulatory factors in each group of MSCs. Expression of indicated gestromal functions for hematopoietic progenitor cells by
presenting distinct spectra of niche cross-talk signals.Transcriptional reprogramming of MSCs with differ-
ent amounts of β-catenin accumulation
We examined the gene expression profiles of MSCs with high
and low levels of β-catenin using a microarray. We first
selected 1000 genes with highly variable expression among
the groups and performed hierarchical clustering (Fig. 6A),
which clearly segregated the control MSCs from MSCs
with β-catenin stabilization. The segregation of expression
profiles was also apparent between MSCs with high and low
levels of β-catenin accumulation, which displayed differen-
tial gene expression in subsets of genes (arrows in Fig. 6A).
However, the level of relative expression (β-catenin versus
controls) measured for each gene was positively correlated
(r = 0.416; Fig. 6B) between MSCs with high and low levels of
β-catenin accumulation. These findings suggest that low andding to the β-catenin level in MSCs. 5-FU BMCs were co-cultured
of hematopoietic progenitors. (A): Fold change of total CD45+
3 experiments, n = 3). **; p b 0.01. (B): Percentage of LSK (Lin−
for 5 days (mean ± SEM values from 3 experiments, n = 3). *;
e. Fold changes in the total number of LSK cells relative to the
riments, n = 3). *; p b 0.05. (D): Expression of hematopoietic
nes was analyzed by RT-PCR using GAPDH as an internal control.
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transcriptomic changes but also differential expression for a
subset of genes.
To further characterize the difference in transcriptomes,
we used Gene Set Enrichment Analysis (GSEA) to investigate
the functional categories of genes that were differentially
expressed in MSCs with high and low levels of β-catenin.
Supplemental Table 1 lists the 17 and 20 categories of gene
sets that were relatively overexpressed in MSCs expressing
high and low levels of β-catenin, respectively. When the
functional relationship among these GO categories was
profiled in a network diagram, 15 and 14 GO categories
showed redundancy into common functional groups in MSCs
with high and low levels of β-catenin, respectively (Figs. 6C,
D). Three gene categories representing signaling pathway/
development, metabolism, and muscle fibers were relatively
overexpressed in MSCs with high levels of β-catenin compared
to those with low levels of β-catenin (Fig. 6C). In contrast,
cell cycle- and DNA metabolism-related GO categories were
overexpressed in MSCs with low levels of β-catenin comparedFigure 6 Transcriptomic changes induced by different levels of β
that showed the largest changes in expression across the expression
and low levels of β-catenin are marked with the corresponding contr
differential expression between MSCs with high and low expression o
different levels of β-catenin expression compared to control-transd
scatter plots compare the SNR from low-BC/MSCs and high-BC/MSCs f
(C): GO categories enriched among genes relatively overexpressed
β-catenin levels are shown as nodes. Edges indicate significant (P b
GO categories. (D): GO categories enriched in genes overexpressed
Table 1 for the full list of 17 and 20 GO categories upregulated in
indicates the members of functional subnetworks in each GO categoto those with high levels of β-catenin (Fig. 6D), consistent
with the findings of higher proliferation and self-renewal in
MSCs expressing low levels of β-catenin. Together, these
results show that MSCs with high and low expression of
β-catenin induce distinct transcription profiles in subsets
of gene groups that belong to distinct functional catego-
ries, thus supporting the molecular basis of distinct
biological impacts in MSCs with different levels of β-catenin
accumulation.Distinct transcriptional milieu under different levels
of β-catenin
Next, we evaluated the molecular basis for the distinct
transcription patterns induced by different levels of β-
catenin in MSCs. Because transactivation of β-catenin in the
promoter region is modulated by protein interactions with
co-factors such as LEF or TCF families (Gan et al., 2008;
Kikuchi et al., 2006), we first compared the expression of-catenin in MSCs. (A): Hierarchical clustering of the 1000 genes
profiles. MSCs transduced with retroviral vectors encoding high
ols for each vector (control). Arrows indicate genes that showed
f β-catenin. (B): Differential gene expression between MSCs with
uced MSCs is calculated as the signal-to-noise ratio (SNR). The
or each gene. A fitted line is shown with the correlation level (r).
in MSCs with high β-catenin levels compared to those with low
10−10; Fisher's exact test) overlap of gene contents between two
in low-BC/MSCs relative to HIGH-BC/MSCs (see Supplemental
high- and low-BC/MSCs, respectively). The color of the nodes
ry.
365Regulation of mesenchymal stromal cells through fine tuning of canonical Wnt signalingthese co-factors in each type of MSC. As shown, MSCs with low
expression of β-catenin exhibited prominently higher levels
of LEF-1 and TCF-1, whereas MSCs with high expression of
β-catenin exhibited profound suppression of LEF-1 with
modest differences in the levels of TCF3 and TCF4 (Figs. 7A,
B). These results suggest that different intracellular levels of
β-catenin could result in distinct transcriptional complexes at
the promoter to generate different transcription profiles.
To further explore the possibility of variation in the
transcriptional milieu under different intracellular levels of
β-catenin, we examined the cellular proteins that interact
with β-catenin in each condition. We performed a proteomic
analysis of intracellular proteins that co-precipitated with
β-catenin using nano-scale liquid chromatography/mass
spectrometry (Nano LC–MS/MS) (Gaspari and Cuda, 2011).
As shown in Supplemental Table 2, extensive differences
were seen in the spectra of proteins that co-precipitated
with each level of β-catenin, suggesting that β-catenin
interacts with different intracellular proteins depending on
its intracellular accumulation levels.
Taken together, these results show that the transcription
milieu varies according to the intracellular concentration of
β-catenin, which thus serves as a distinct transactivationFigure 7 Changes in the expression of co-factors for β-catenin wit
levels of β-catenin were analyzed for expression of co-factors for
co-factor compared to those in control MSCs were analyzed by real-t
(mean ± SEM values from 3 experiments, n = 3). *; p b 0.05 **; p b
MSC expressing high and low levels of β-catenin. (C): Hypothetic
signaling in MSCs. Differences in the intensity of Wnt/β-catenin signa
i.e., TCF-1 is dominantly up-regulated in Low-BC, but Lef-1 is profou
intracellular proteins (marked with blue and red hexagon) interact
under high and low levels of β-catenin to induce distinct transcriptio
MSCs under these two conditions. * L1: LEF-1, T1: TCF-1, T3: TCF-3
levels in the cells, and hexagons denote intracellular proteins interafactor that can induce distinct transcription profiles in MSCs
and thereby produce distinct functional outcomes.Discussion
Recent studies have focused on signals that regulate prolifer-
ation/differentiation and stromal function under various
physiological and pathological conditions. Of these regulatory
signals, canonical Wnt signals have been implicated in the
regulation of MSCs either by controlling the expression of
cross-talk molecules such as Jagged-1 or dll-1 (Kim et al.,
2009) or by controlling MSC differentiation into osteogenic or
adipogenic lineages (Ling et al., 2009; Takada et al., 2009).
Moreover, constitutive stabilization of β-catenin in bone
marrow stromal cells was associated with development of
myeloproliferative disease (Kode et al., 2014), indicating that
canonical Wnt signaling in stromal cells should be fine-tuned
for coordinated microenvironmental regulation of hematopoi-
etic activity.
However, little is known regarding the precise biological
impact of the signal intensity of canonical Wnt signaling
in MSCs. Moreover, the effects of Wnt signaling on theh respect to β-catenin levels. (A): MSCs expressing high and low
β-catenin transactivation. Relative expression levels of each
ime quantitative RT-PCR (RQ-PCR) after normalization to GAPDH
0.01. (B): Western blot for co-factors in the nuclear extracts of
al model for concentration-specific effects of Wnt/β-catenin
ling induce differences in the transcription milieu for β-catenin,
ndly down-regulated in High-BC. In addition, distinct spectra of
with β-catenin. Thus, different protein complexes are formed
n profiles and therefore generate distinct biological functions in
, T4: TCF-4. The size of each factor denotes relative expression
cting with β-catenin.
366 J.-A. Kim et al.differentiation of MSCs is controversial (Boland et al., 2004;
Cook et al., 2014; Gaur et al., 2005; Kawai et al., 2007),
raising the possibility that the regulatory effects of canonical
Wnt signals in MSCs could be more complex than previously
thought.
Therefore, to investigate the possibility that the biological
characteristics of MSCs are regulated by fine-tuning of Wnt
signaling strength, we established MSCs with high and low
expression of β-catenin by transduction of the cells with two
different retroviral vectors. From this approach, we found
that two distinct aspects of MSC function were controlled by
the intensity of Wnt/β-catenin signals, i.e., proliferation and
self-renewal of MSCs were promoted only under low levels
of Wnt/β-catenin, whereas osteogenic differentiation was
promoted in a manner proportional to the intensity of the Wnt
signals.
Moreover, MSCs proliferating under low Wnt/β-catenin
exhibited higher expression of pluripotency genes such as
Oct-4, Sox-2, and Nanog (Greco et al., 2007; Tsai et al.,
2012), indicative of a more primitive state, whereas the
cells exhibited more committed osteoblast-like properties
under high Wnt/β-catenin.
Interestingly, studies have shown that the characteristics
of primitive MSCs derived from embryonic or induced
pluripotent stem cells as well as MSCs from fetal tissue
exhibit higher levels of pluripotent gene expression, higher
CFU-F and proliferation together with higher osteogenic, but
not adipogenic differentiation potential compared to adult
tissue-derived MSCs (Boyd et al., 2009; Chen et al., 2012)
(Guillot et al., 2007; Zhang et al., 2009), which was similarly
observed among MSCs with early and late passages during
serial subculture (Vacanti et al., 2005). Thus, taken these
findings together, MSCs under low Wnt/β-catenin levels
mimic the primitive MSCs sharing exhibiting common
functional characteristics with those MSCs.
Of note, differences in the accumulation levels of
β-catenin in MSCs also resulted in distinct stimulatory
effects on hematopoietic progenitor cells, i.e., whereas
MSCs with low expression of β-catenin better supported the
proliferation of hematopoietic cells than MSCs with high
expression of β-catenin, maintenance of the undifferentiat-
ed state was better supported by MSCs with high levels of
β-catenin.
Together, these findings suggest that the MSCs exhibit
distinct biological responses to physiological conditions and
exert distinct influences on the tissue regenerative process
depending on the strength of Wnt/β-catenin signaling in
their microenvironment. Although further studies on the
physiological significance of such regulation of niche activity
are warranted, our findings point to the importance of
fine-tuning Wnt/β-catenin signaling for coordination of
regulatory effects in MSCs.
At present, the mechanisms underlying the concentration-
specific effects of Wnt/β-catenin signaling remain unclear.
However, our study shows that β-catenin induces distinct
transcriptomic changes depending on the level of β-catenin
accumulation, especially for subsets of genes in distinct
functional groups of gene ontology. In particular, low levels
of β-catenin in MSCs resulted in up-regulation of genes
involved in cell cycle and DNA metabolism, whereas high
levels of β-catenin caused up-regulation of genes involved
in signaling pathway/development and metabolism. Thus,β-catenin can serve as a distinct transactivation molecule
depending on its level of accumulation in the cells to induce
different transcriptomic changes in the cells.
Although the molecular basis for the distinct trans-
activation of β-catenin remains unclear, our study raises the
possibility that the transcriptional milieu at the target
promoters could vary according to the level of β-catenin
accumulation. Supporting this possibility, MSCs expressing
different levels of β-catenin exhibited different intracellular
expression of co-factors, such that high and low levels of
β-catenin resulted in different levels of LEF-1 and TCF-1.
Thus, it is possible that different levels of β-catenin result in
the formation of a distinct transcription complex at the target
promoters, thus resulting in different components of the
transcription milieu. Moreover, nano-scale LC/mass spectro-
photometry showed that β-catenin interacts with different
intracellular proteins, as evidenced by the distinct spectrum
of co-precipitated proteins specific to each concentration of
β-catenin.
Therefore, out study shows that different intracellular
levels of β-catenin can affect the transcription milieu, and
thus β-catenin may serve as a distinct transactivation
molecule to produce distinct biological effects in MSCs
(schematically shown in Fig. 7C).
Of note, our finding of distinct transactivation with
different intracellular levels of β-catenin could provide a
mechanism for broader spectra of stem cell regulation by
Wnt signals, as several studies have shown that the
regulatory effects of Wnt signals on HSCs are dependent on
the intensity of the signals (Luis et al., 2011). Similarly,
differentiation of ES cells towards specific lineages was
influenced by the strength of Wnt signals (Kielman et al.,
2002; Reya and Clevers, 2005), providing a common scheme
for regulation by Wnt signals. In this sense, it is plausible
that the current paradigm of concentration-specific regula-
tion by Wnt/β-catenin signaling is conserved over a broad
extent of tissue regeneration and that various types of stem
cells and their niche function can be regulated through fine
tuning of Wnt/β-catenin signaling. Further studies are
necessary for a more complete understanding of the
regulation of various tissue regenerative processes by Wnt/
β-catenin signaling.
Nevertheless, our study shows that different intracellular
levels of β-catenin in MSCs may result in distinct biological
responses of MSCs and that β-catenin serves as a distinct
transactivation molecule that regulates MSC function ac-
cording to Wnt signaling intensity. Our study provides a
novel insight into the importance of fine tuning of Wnt/
β-catenin signals for coordination of various regenerative
biological functions.
Supplementary data to this article can be found online at
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